Posted On: 12/22/2016 6:29:17 PM
Post# of 103888
$SGYP: Synergy Pharmaceuticals Announces Positive Results in Second Phase 3 Trial of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)
http://www.otcmarkets.com/stock/SGYP/news
http://www.otcmarkets.com/stock/SGYP/news
(0)
(0)
Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.
Scroll down for more posts ▼
